On the whole, pure monogenic forms of PD are rare and although variants in genes like SNCA, PINK1, PRKN, and DJ1 are well established causes of disease it would be difficult to collect enough patients to create an appropriately powered clinical trial in these populations. Here, PRKN is linked to Parkinson disease.